Arm Shares Rebound as AI and Data-Center Growth Boost Investor Confidence
Arm stock rises after analysts praise earnings, highlighting AI-driven data-center growth despite smartphone market concerns.
NOTRELOAD AI
MGM Resorts Posts Strong Q4 Growth Driven by Casino Revenue
MGM Resorts expects Q4 profit to more than double to $293.6M, beating analyst estimates, while BetMGM swings to profitability with strong online gaming growth.
Amgen Beats Q4 Expectations Despite FDA Drug Controversy
Amgen (AMGN) reports strong Q4 2025 earnings with $9.87B revenue, beating estimates. Company defies FDA request to withdraw Tavneos while advancing obesity drug MariTide through trials.
IonQ Under Fire: Pentagon Contracts May Not Be What They Seem
Short-seller report claims quantum computing company IonQ lost vital Pentagon funding that made up 86% of revenue, acquired non-quantum businesses to hide losses, and insiders sold $397M in stock.
Cumberland Pharma Gets FDA Fast Track for Groundbreaking DMD Heart Treatment
Cumberland Pharmaceuticals receives FDA Fast Track designation for ifetroban, a promising new oral therapy targeting fatal heart disease in Duchenne muscular dystrophy patients.
AbbVie Beats 2026 Profit Forecast Despite Market Concerns Over Drug Portfolio Mix
AbbVie (ABBV) reports strong Q4 earnings and raises 2026 profit outlook to $14.37-$14.57 per share, beating Wall Street estimates, though investors worry about Humira decline and aesthetics challenges.